Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 64 users online. 5 members and 59 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

92 results in 0.0116 seconds.
Keywords
Members
Tags
update x
  •  

  • U.S. Department of State publishes Update on Department Transition Efforts and Travel 

    U.S. Department of State publishes Update on Department Transition Efforts and Travel| site |

    (Information contained in U.S. Department of State's press release press statement attributed to Morgan Ortagus, Department Spokesperson: January 12, 2021)


    January 12, 2021
    Press Statement

    Morgan Ortagus, Department Spokesperson

    The Department of State is well along in its transition efforts with President-elect Biden’s team. We are fully committed to the completion of a smooth and orderly transition process to be finalized over the next 8 days. Both the Department and the President-elect’s team have been fully engaged for several weeks toward this end, and we are pleased with the level of cooperation and professionalism that has been displayed. We are expecting shortly a plan from the incoming administration identifying the career officials who will remain in positions of responsibility on an acting basis until the Senate
    ...
    See more | Go to post

  • Coronavirus COVID-19 Update - - - January 8, 2021

    Coronavirus COVID-19 Update - - - January 8, 2021

    Coronavirus (COVID-19) Update: January 8, 2021 | site |



    (The following is part of the information contained in U.S. Food and Drug Administration [FDA] press release: January 8, 2021)


    The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
    • The FDA alerted clinical laboratory staff and health care providers that genetic variants of SARS-CoV-2 may lead to false negative results with molecular tests for SARS-CoV-2. The Letter to Clinical Laboratory Staff and Health Care Providers includes important information about potential false negative results with molecular tests, including:
      • Details on the effect of genetic variants on test performance.
      • Recommendations for clinical laboratory staff and health care providers.
      • Actions the FDA has taken.
      • Instructions for reporting problems with a test.
    • This week, the FDA posted a new webpage, Moderna COVID-19 Vaccine Frequently
    ...
    See more | Go to post

  • U.S. Internal Revenue Service releases 2020 Progress Update

    U.S. Internal Revenue Service releases 2020 Progress Update

    U.S. Internal Revenue Service releases 2020 Progress Update | site |


    IRS says "Annual report details unprecedented year"


    (Information contained in U.S. Internal Revenue Service [IRS] press release dated: January 5, 2021)

    Washington - - The Internal Revenue Service today released its 2020 annual report describing the agency's work delivering taxpayer service and compliance efforts during COVID-19 while spotlighting actions taken by IRS employees to help people during the challenging year.

    "Internal Revenue Service Progress Update/Fiscal Year 2020 – Putting Taxpayers First " outlines how the agency overcame difficulties during the pandemic to deliver Economic Impact Payments in record time. At the same time, IRS employees made adjustments to complete a successful filing season despite office closures and the latest tax deadline ever. "The COVID-19 pandemic presented some of the greatest challenges to the IRS in
    ...
    See more | Go to post

  • Transcript of CDC Update on COVID-19 - - January 6, 2021

    Transcript of CDC Update on COVID-19 - - January 6, 2021

    Transcript of Centers for Disease Control and Prevention Update on COVID-19 - - January 6, 2021 | site |




    (Information contained in Centers for Disease Control and Prevention [CDC] press release dated: January 6, 2021)




    Please Note: This transcript is not edited and may contain errors.


    OPERATOR: AT THIS TIME, ALL PARTICIPANTS ARE ON LISTEN-ONLY MODE. SO, IF YOU WOULD LIKE TO ASK A QUESTION, PLEASE PRESS STAR AND THEN ONE.

    TODAY’S CONFERENCE IS BEING RECORDED. IF YOU HAVE ANY OBJECTIONS, YOU MAY DISCONNECT AT THIS TIME. AND NOW I WOULD LIKE TO TURN THE MEETING OVER TO MR. BENJAMIN HAYNES. SIR YOU MAY BEGIN.

    HAYNES: THANK YOU, BRITTANY. AND THANKS TO EVERYONE WHO HAS JOINED US FOR TODAY’S BRIEFING TO DISCUSS VACCINE SAFETY. WE ARE JOINED BY THE DIRECTOR OF CDC’S NATIONAL CENTER AND IS SENIOR FEDERAL OFFICIAL LEADING TODAY’S VACCINE EFFORTS. WE WILL BE JOINED BY DR. TOM CLARK,
    ...
    See more | Go to post

  • U.S. Food and Drug Administration Coronavirus COVID-19 Update - - January 5, 2021

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: January 5, 2021 | site |



    (Information included in U.S. Food and Drug Administration [FDA] press release dated: January 5, 2021)


    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • Today, the FDA posted a new webpage on the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) highlighting authorities that are intended to enhance the FDA’s ability to identify, prevent, and mitigate possible drug shortages by, among other things, enhancing the FDA’s visibility into drug supply chains.

    The CARES Act amended the Federal Food, Drug, and Cosmetic (FD&C) Act to:
    Expand the requirement for manufacturers of certain drugs to provide information on permanent discontinuances and interruptions in manufacturing that may lead to a meaningful disruption in supply to the FDA. Include
    ...
    See more | Go to post

  • Census Bureau Update on 2020 Census

    Census Bureau Update on 2020 Census

    Census Bureau Update on 2020 Census | site |


    (Information contained in U.S. Census Bureau press release dated: December 30, 2020)

    DEC. 30, 2020 - - Data collection is just one part of producing a complete and accurate 2020 Census. Since mid-October, Census Bureau experts have been hard at work on processing the data.

    As issues that could affect the accuracy of the data are detected, they are corrected. This important process, which has been a part of every decennial census, is critical to produce data that can be used for apportioning seats in the House of Representatives among the states.

    The schedule for reporting this data is not static. Projected dates are fluid. We continue to process the data collected and plan to deliver a complete and accurate state population count for apportionment in early 2021, as close to the statutory deadline as possible.
    ...
    See more | Go to post

  • U.S. Food and Drug Administration Coronavirus COVID-19 Update - - - December 30, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 30, 2020 | site |



    (Information contained in U.S. Food and Drug Administration [FDA] press release: December 30, 2020)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • Today, the FDA published a new toolkit to help stakeholders communicate in English and Spanish about hand sanitizer safety and use during the COVID-19 pandemic. New materials include social media messages and graphics, consumer information, and health professional messaging. Furthermore, a new COVID-19 Communication Toolkits webpage provides links to all FDA toolkits on COVID-19 topics to help everyone communicate accurate and timely information to patients, the public, and health care professionals.
    ...
    See more | Go to post

  • Transcript of CDC Update on COVID-19 - - December 30, 2020

    Transcript of CDC Update on COVID-19 - - December 30, 2020

    Transcript: Centers for Disease Control and Prevention Update on COVID-19 - - December 30, 2020 | site |




    (Information contained in Centers for Disease Control and Prevention [CDC] press release: December 30, 2020)



    Please Note: This transcript is not edited and may contain errors.

    OPERATOR: WELCOME AND THANK YOU FOR STANDING BY. ALL LINES HAVE BEEN PLACED IN A LISTEN ONLY MODE FOR TODAY’S PREPARATION. THE CALL IS BEING RECORDED. IF YOU HAVE ANY OBJECTIONS, YOU MAY DISCONNECT AT THIS TIME. I WILL NOW INTRODUCE YOUR CONFERENCE HOST, MR. BENJAMIN HAYNES. YOU MAY BEGIN.

    HAYNES: THANK YOU EVERYONE WHO HAS JOINS US TO DISCUSS TWO, NEW VARIANTS OF THE VIRUS THAT CAUSES COVID-19 AS WELL AS COVID-19 VACCINES. WE ARE JOINED BY DR. HENRY WALKE, THE INCIDENT MANAGER FOR CDC’S COVID-19 RESPONSE AND DR. NANCY MESSONNIER, DIRECTOR CDC’S NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES, AND THE SENIOR FEDERAL
    ...
    See more | Go to post

  • FDA Coronavirus COVID-19 Update - - - December 28, 2020

    FDA Coronavirus COVID-19 Update - - - December 28, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 28, 2020 | site |



    (Information contained in U.S. Food and Drug Administration [FDA] press release: December 28, 2020)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • On Dec. 23, the FDA updated the Device Shortage List on our web page that lists Medical Device Shortages During the COVID-19 Public Health Emergency. Specifically, the FDA added the following device types in the testing supplies and equipment category: pipette tips (product codes LXG and PPM) and micro pipettes (product code JRC). The FDA also added clarifying notes and links to more resources in the “Additional Information” column, as well as adding clarity to the categories, such as grouping gloves under “Personal Protective Equipment – Gloves.” The device shortage list reflects the categories of
    ...
    See more | Go to post

  • NHTSA Announces 2020 Update on AEB Installation by 20 Automakers

    NHTSA Announces 2020 Update on AEB Installation by 20 Automakers

    National Highway Traffic Safety Administration Announces 2020 Update on Automatic Emergency Braking Installation by 20 Automakers | site |



    (Information contained in National Highway Traffic Safety Administration [NHTSA] press release dated: December 17, 2020)

    December 17, 2020 | Washington, DC - - The U.S. Department of Transportation’s National Highway Traffic Safety Administration today announced the progress of 20 automakers toward manufacturing passenger vehicles with low-speed automatic emergency braking (AEB) systems. This is part of a voluntary effort by automakers in collaboration with NHTSA to equip almost all new passenger vehicles with low-speed AEB, including forward collision warning, by August 31, 2023. Ten manufacturers – Audi, BMW, Hyundai, Mazda, Mercedes-Benz, Subaru, Tesla, Toyota, Volkswagen, and Volvo – are already installing AEB in all new passenger vehicles, three years ahead of schedule. During the period from...
    See more | Go to post

  • U.S. Food and Drug Administration Coronavirus COVID-19 Update - - - December 22, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 22, 2020 | site |



    (Information contained in U.S. Food and Drug Administration [FDA] press release: December 22, 2020)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • The FDA has posted translations of the Moderna COVID-19 Vaccine fact sheet for recipients and caregivers, and the fact sheet for healthcare providers in languages including: Arabic, Chinese, French, Spanish, Tagalog, and Vietnamese. We will post additional language translations of the fact sheet for recipients and caregivers to this page as we receive the translations.
    • The FDA recently approved three abbreviated new drug applications (ANDAs):
    On Dec. 18, one ANDA for etomidate injection, indicated for the induction of general anesthesia. The most common side effects of etomidate injection are venous pain on injection and
    ...
    See more | Go to post

  • FDA Coronavirus (COVID-19) Update - - - December 21, 2020

    FDA Coronavirus (COVID-19) Update - - - December 21, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 21, 2020 | site |


    (Information contained in U.S. Food and Drug Administration [FDA] press release: December 21, 2020)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • The FDA has posted translations of the Pfizer-BioNTech COVID-19 Vaccine fact sheet for recipients and caregivers in languages including: Arabic, Burmese, Cherokee, Chinese (Simplified and Traditional), Chuukese, German, Haitian Creole, Hindi, Hmong, Korean, Mam, Polish, Portuguese, Russian, Spanish, Somali, Tagalog, Vietnamese, and Yiddish. We will post additional language translations of the fact sheet for recipients and caregivers to this page as we receive the translations.
    • Today, the agency updated its FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures, and highlights on
    ...
    See more | Go to post

  • U.S. Food and Drug Administration Coronavirus COVID-19 Update - - - December 17, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 17, 2020| site |



    (Information contained in U.S. Food and Drug Administration [FDA] press release: December 17, 2020)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • Today, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made up of independent scientific and public health experts from around the country, met to discuss a request for emergency use authorization (EUA) for a vaccine for COVID-19 prevention, submitted by ModernaTX, Inc. This meeting is an important step in the review process, providing an opportunity for outside experts to provide valuable advice and input for the agency to consider as part of its review. Importantly, the final decision about whether to authorize the vaccine for emergency use will be made by FDA’s career officials.
    • Also
    ...
    See more | Go to post

  • U.S. Food and Drug Administration Coronavirus COVID-19 Update - - - December 16, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 16, 2020 | site |


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: December 16, 2020)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • Today, the FDA issued a new Emergency Use Authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test for at-home use with a prescription. The BinaxNOW COVID-19 Ag Card Home Test is an antigen test that detects fragments of proteins from SARS-CoV-2, the virus that causes COVID-19, from a nasal swab sample. It is authorized for use at home with self-collected samples in individuals age 15 years or older who are suspected of having COVID-19 by a health care provider within the first seven days of symptom onset. The test is also for use with individuals aged four years or older who
    ...
    See more | Go to post

  • Excerpt from FDA Coronavirus COVID-19 Update - - - December 14, 2020

    Excerpt from FDA Coronavirus COVID-19 Update - - - December 14, 2020

    Excerpts from U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 14, 2020 | site |




    (The following are EXCERPTS from information contained in a U.S. Food and Drug Administration [FDA] press release: December 14, 2020)

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • Yesterday, the FDA posted the review memorandum outlining the basis of the agency’s decision to authorize the Pfizer-BioNTech COVID-19 Vaccine. To ensure all Americans can have trust and confidence in the carefulness of FDA’s review, we have made, and will continue to make, the vaccine review process as transparent as possible.
    • On Dec. 11, the agency approved an abbreviated new drug application for midazolam injection, indicated for preoperative sedation/anxiolysis (anxiety)/amnesia; as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic
    ...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    U.S. Department of State publishes Update on Department Transition Efforts and Travel 
    by Staff Reporter 1
    U.S. Department of State publishes Update on Department Transition Efforts and Travel| site |

    (Information contained in U.S. Department of State's press release press statement attributed to Morgan Ortagus, Department Spokesperson: January 12, 2021)


    January 12, 2021
    Press Statement

    Morgan Ortagus, Department Spokesperson

    The Department of State is well along in its transition efforts with President-elect Biden’s team. We are fully committed to the completion of a smooth and orderly transition process to be finalized over the next 8 days. Both the Department and the President-elect’s team have been fully engaged for several weeks toward this end, and we are pleased with the level of cooperation and professionalism that has been displayed. We are expecting shortly a plan from the incoming administration identifying the career officials who will remain in positions of responsibility on an acting basis until the Senate
    ...
    01-13-2021, 08:07 AM
  • Staff Reporter 1
    Coronavirus COVID-19 Update - - - January 8, 2021
    by Staff Reporter 1
    Coronavirus (COVID-19) Update: January 8, 2021 | site |



    (The following is part of the information contained in U.S. Food and Drug Administration [FDA] press release: January 8, 2021)


    The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
    • The FDA alerted clinical laboratory staff and health care providers that genetic variants of SARS-CoV-2 may lead to false negative results with molecular tests for SARS-CoV-2. The Letter to Clinical Laboratory Staff and Health Care Providers includes important information about potential false negative results with molecular tests, including:
      • Details on the effect of genetic variants on test performance.
      • Recommendations for clinical laboratory staff and health care providers.
      • Actions the FDA has taken.
      • Instructions for reporting problems with a test.
    • This week, the FDA posted a new webpage, Moderna COVID-19 Vaccine Frequently
    ...
    01-09-2021, 05:39 AM
  • Staff Reporter 1
    U.S. Internal Revenue Service releases 2020 Progress Update
    by Staff Reporter 1
    U.S. Internal Revenue Service releases 2020 Progress Update | site |


    IRS says "Annual report details unprecedented year"


    (Information contained in U.S. Internal Revenue Service [IRS] press release dated: January 5, 2021)

    Washington - - The Internal Revenue Service today released its 2020 annual report describing the agency's work delivering taxpayer service and compliance efforts during COVID-19 while spotlighting actions taken by IRS employees to help people during the challenging year.

    "Internal Revenue Service Progress Update/Fiscal Year 2020 – Putting Taxpayers First " outlines how the agency overcame difficulties during the pandemic to deliver Economic Impact Payments in record time. At the same time, IRS employees made adjustments to complete a successful filing season despite office closures and the latest tax deadline ever. "The COVID-19 pandemic presented some of the greatest challenges to the IRS in
    ...
    01-07-2021, 09:17 PM
  • Staff Reporter 1
    Transcript of CDC Update on COVID-19 - - January 6, 2021
    by Staff Reporter 1
    Transcript of Centers for Disease Control and Prevention Update on COVID-19 - - January 6, 2021 | site |




    (Information contained in Centers for Disease Control and Prevention [CDC] press release dated: January 6, 2021)




    Please Note: This transcript is not edited and may contain errors.


    OPERATOR: AT THIS TIME, ALL PARTICIPANTS ARE ON LISTEN-ONLY MODE. SO, IF YOU WOULD LIKE TO ASK A QUESTION, PLEASE PRESS STAR AND THEN ONE.

    TODAY’S CONFERENCE IS BEING RECORDED. IF YOU HAVE ANY OBJECTIONS, YOU MAY DISCONNECT AT THIS TIME. AND NOW I WOULD LIKE TO TURN THE MEETING OVER TO MR. BENJAMIN HAYNES. SIR YOU MAY BEGIN.

    HAYNES: THANK YOU, BRITTANY. AND THANKS TO EVERYONE WHO HAS JOINED US FOR TODAY’S BRIEFING TO DISCUSS VACCINE SAFETY. WE ARE JOINED BY THE DIRECTOR OF CDC’S NATIONAL CENTER AND IS SENIOR FEDERAL OFFICIAL LEADING TODAY’S VACCINE EFFORTS. WE WILL BE JOINED BY DR. TOM CLARK,
    ...
    01-07-2021, 06:39 AM
  • Staff Reporter 1
    U.S. Food and Drug Administration Coronavirus COVID-19 Update - - January 5, 2021
    by Staff Reporter 1
    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: January 5, 2021 | site |



    (Information included in U.S. Food and Drug Administration [FDA] press release dated: January 5, 2021)


    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • Today, the FDA posted a new webpage on the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) highlighting authorities that are intended to enhance the FDA’s ability to identify, prevent, and mitigate possible drug shortages by, among other things, enhancing the FDA’s visibility into drug supply chains.

    The CARES Act amended the Federal Food, Drug, and Cosmetic (FD&C) Act to:
    Expand the requirement for manufacturers of certain drugs to provide information on permanent discontinuances and interruptions in manufacturing that may lead to a meaningful disruption in supply to the FDA. Include
    ...
    01-06-2021, 02:05 AM

Menu

Collapse

Menu

Collapse

Working...
X